Market Place
Sourcing Support
All News #Library
Biotech
Oncoinvent Expands Radspherin Patent Protection
19 Mar 2026 //
PHARMIWEB
Oncoinvent ASA: Second half 2025 results
26 Feb 2026 //
PR NEWSWIRE
Oncoinvent: Positive 24-Month Radspherin Data in Ovarian Cancer
17 Feb 2026 //
PHARMIWEB
Oncoinvent Expands Phase 2 Trial With Four New Recruitment Sites
29 Jan 2026 //
PHARMIWEB
Oncoinvent Announces Phase 1 Radspherin Results in Ovarian Cancer
11 Dec 2025 //
PHARMIWEB
Oncoinvent Releases Positive Phase 1 Radspherin to Treat Cancer
08 Oct 2025 //
PR NEWSWIRE
Oncoinvent ASA Advances Phase 2 Ovarian Cancer Program
27 Aug 2025 //
PR NEWSWIRE
Ber Gen Bio and Oncoinvent Propose Merger and Rights Issue
30 Jun 2025 //
PR NEWSWIRE
Oncoinvent Reports Positive Final Data from Radspherin® Trial
18 Jun 2025 //
PR NEWSWIRE
Oncoinvent to Present at TD Cowen Annual Health Care Conference
26 Feb 2025 //
BUSINESSWIRE
Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference
21 Feb 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.